Monopar Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Monopar Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Monopar Therapeutics Inc
Rating: 1.53891675
Author: Trendlyne DVM scores

about

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prev...

44.21 5.37 (13.83%)

1805.60% Gain from 52W Low

34,617

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.7 / 100

Technically Neutral

56.9 / 100

No estimates available

Monopar Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Monopar Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prev...

1805.60% Gain from 52W Low

SWOT Analysis

Monopar Therapeutics Inc Live Price Chart